Ireland–Claisen rearrangement
Ireland–Claisen rearrangement is a chemical reaction that involves the stereocontrolled rearrangement of allyl esters to γ,δ-unsaturated carboxylic acids using a base. This reaction is a variant of the classic Claisen rearrangement, and it was first reported by Robert Ireland in 1972. The Ireland–Claisen rearrangement has become a valuable tool in organic synthesis, especially in the synthesis of complex natural products due to its ability to efficiently construct carbon-carbon bonds with high stereocontrol.
Mechanism[edit | edit source]
The Ireland–Claisen rearrangement proceeds through a six-membered cyclic transition state. Initially, the reaction involves the deprotonation of the allyl ester by a strong base, typically a lithium diisopropylamide (LDA) or other non-nucleophilic bases, to form an enolate. This enolate then undergoes a [6,3]-sigmatropic rearrangement, leading to the formation of an allylic carboxylate intermediate. Subsequent protonation yields the γ,δ-unsaturated carboxylic acid. The stereochemistry of the product is determined by the stereochemistry of the starting material and the mechanism of the rearrangement, which often allows for high levels of stereocontrol.
Applications[edit | edit source]
The Ireland–Claisen rearrangement has found extensive applications in the synthesis of complex organic molecules, including natural products and pharmaceuticals. Its ability to form carbon-carbon bonds while introducing functional groups in a stereocontrolled manner makes it a powerful tool in the arsenal of organic chemists. For example, it has been used in the synthesis of (-)-swainsonine, a potent inhibitor of glycoprotein processing enzymes, and in the construction of the C15-C21 fragment of the antitumor agent discodermolide.
Variants[edit | edit source]
Several variants of the Ireland–Claisen rearrangement have been developed to expand its utility and applicability. These include the asymmetric Ireland–Claisen rearrangement, which employs chiral auxiliaries or chiral bases to induce asymmetry in the product, and the intramolecular Ireland–Claisen rearrangement, which is used to construct cyclic compounds. Other notable variants include the silyl ketene acetal version, which allows for the use of less reactive esters, and the heteroatom-substituted Ireland–Claisen rearrangement, which introduces heteroatoms into the rearranged product.
Limitations[edit | edit source]
Despite its versatility, the Ireland–Claisen rearrangement has some limitations. The requirement for strong bases can lead to side reactions, especially in molecules with sensitive functional groups. Additionally, the reaction conditions may not be suitable for all substrates, limiting its applicability in certain cases.
Conclusion[edit | edit source]
The Ireland–Claisen rearrangement is a powerful and versatile tool in organic synthesis, offering chemists the ability to construct complex molecules with high levels of stereocontrol. Its variants and applications continue to expand, making it an indispensable reaction in the field of organic chemistry.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD